Navigation Links
Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,,AN2690; Findings Published in Science

e European Molecular Biology Laboratory (EMBL) in Grenoble, France, led by Stephen Cusack, Ph.D., then determined how the drug worked at the molecular level.

By examining fungal strains resistant to the drug, scientists determined that the drug blocks protein synthesis by inhibiting a protein called leucyl-tRNA synthetase, or LeuRS. LeuRS plays a key role in translating the genetic code in both fungus and bacteria, and blocking its action keeps those organisms from growing, effectively stopping the infection. Researchers found that replacing the boron atom in AN2690 with a carbon atom inactivated the drug, underscoring the importance of the boron chemistry.

While the anti-fungal effect of the LeuRS protein inhibition by boron-containing compounds has been established by the clinical results seen for AN2690, other proteins from the same family, known as aminoacyl-tRNA synthetases, are well-validated targets for antibiotic drug development.

"Now that we know how AN2690 works, the same approach could be adapted to target other aminoacyl-tRNA synthetases with editing sites, which are also excellent targets for anti-microbial drugs," said Cusack, whose group performed the X-ray crystallography which revealed how AN2690 binds to LeuRS.

Anacor is now leveraging that knowledge to create new boron-containing drugs designed to target systemic bacterial infections.

"Drug-resistant bacteria are a large and growing problem in the hospital and in the community, which makes the discovery of novel antibiotics a public health necessity," said David Perry, Anacor's chief executive officer. "We believe that our approach may hold great promise in the development of these needed therapies."

Boron is a naturally occurring element found in the soil and in water supplies. It is an essential micronutrient for plants, and the chemical is commonly present in its elemental form in the human bloodstream. Despite the ubiquity of the element, little work
'"/>




Page: 1 2 3

Related medicine technology :

1. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
2. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
3. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
4. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
5. NIDA Study Identifies Genes That Might Help Some People Abstain from Smoking
6. Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
10. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
11. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
Post Your Comments:
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Abaxis, Inc. ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Severson , Chairman and Chief Executive Officer, will present ... September 10, 2014 at 10:20 a.m. ET. The conference ... in New York City . ...
(Date:9/2/2014)... , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Morgan Stanley ... , New York on Tuesday, September ... parties are invited to listen to the live audio webcast ... at www.hologic.com/investors-overview . An archive of the presentation will ...
Breaking Medicine Technology:ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2
... MADISON, Wis., Aug. 8, 2011 Symphony Corporation, ... the acquisition of JGI, a New Jersey-based Human ... significant presence in the healthcare industry nationally.  Symphony,s ... its offerings to provide the highest level of ...
... DIEGO, Aug. 8, 2011 HUYA Bioscience International, a ... strategic partnership with the Shanghai Jiao Tong University School ... assist King,s Lab in accelerating the development of their ... provides HUYA with access to and first review of ...
Cached Medicine Technology:Symphony Corporation Acquires JGI to Provide End-to-End Services for Healthcare IT 2HUYA Bioscience International and Shanghai Jiao Tong University King's Lab Form Alliance 2HUYA Bioscience International and Shanghai Jiao Tong University King's Lab Form Alliance 3
(Date:9/2/2014)... news release is available in Spanish . ... Granada have found, through an experiment conducted on rats, that ... of great use for groups with bone disease problems, such ... also revealed that vegetal proteinin the case of the present ... protein), since the former increased the level of calcium in ...
(Date:9/2/2014)... Somerset, N.J. (PRWEB) September 02, 2014 ... delivery technologies and development solutions for drugs, biologics ... support of its strategic partner, Eli Lilly’s growth, ... clinical packaging lines at its Philadelphia Clinical Supply ... prefilled syringe packaging capabilities in its clinical supply ...
(Date:9/2/2014)... Australia (PRWEB) September 02, 2014 The ... has fluctuated over the past five years. Industry revenue ... of 1.0% over the five years through 2014-15, following ... have faced increasing external competition from alternate forms of ... and other online gambling platforms have all become increasingly ...
(Date:9/2/2014)... Based on new studies, concerns ... kidney and spleen surgeries, have continued to mount. ... patients. , An article in the "Public ... Titilope Oduyebo and Bradley J. Quade called, "Peritoneal ... on Nov 26, 2012 defines a morcellator ...
(Date:9/2/2014)... 2014 (HealthDay News) -- When it comes to excess pounds ... a new study finds. The research found that belly ... odds for high blood pressure more than overall body fat. ... high blood pressure. But it wasn,t clear how the location ... researchers at University of Texas Southwestern Medical Center in Dallas. ...
Breaking Medicine News(10 mins):Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 3Health News:'Spare Tire' May Be Especially Bad for Your Blood Pressure 2
... simple blood test corresponding to the follicular phase (days ... optimal scheduling of breast MRI exams in premenopausal women ... repeat scans and non-diagnostic tests patients experience and providing ... to a study published in the December issue of ...
... Nov. 20 As more red flags are uncovered about ... played a significant role in enabling this to happen. Has ... of inclusion and acceptance into a dangerous unwillingness to acknowledge ... and author Dr. Gaby Cora asserts that dangerous behavior in ...
... , Unique Survey Takes First-Time Look at Employers, ... 20 More employers are taking steps to improve their ... prescribed, a move that could stave off more serious and ... the National Pharmaceutical Council (NPC). , Medication compliance, sometimes ...
... Keep your children ... Kiley. , ... 2009 -- During the exciting weeks leading up to the holidays, many people find themselves ... the spirit of the season. Among all this holiday cheer we often forget that unsafe ...
... ... a line of pacifiers affixed to stuffed animals, she not only thought she created ... years later, apparently someone else thought so as well, as Williams was one of ... , ...
... WOONSOCKET, R.I., Nov. 20 CVS/pharmacy kicks off its annual ... St. Jude Children,s Research Hospital Thanks and Giving ... CVS/pharmacy store colleagues will encourage customers to add $1 to ... of St. Jude, one of the world,s premier centers for ...
Cached Medicine News:Health News:Psychiatrist Says Political Correctness Is Costing Lives 2Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 2Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 3Health News:Parents: Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M. Kiley 2Health News:Parents: Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M. Kiley 3Health News:Pacimals Founder Recognized in Time Magazine's "Inventors and Their Inventions" Special Section 2Health News:CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital 2
... Wheaton Harness™ A Pavlik-type harness with ... the treatment of congenital hip dysplasia. ... lining, and antislip foot pieces.,Color-coded anterior ... adjustments can be made while the ...
... cost walker features a non-skid rocker outsole ... profile design minimizes leg length discrepancy. Three ... strapping quick and easy. Steel uprights are ... ankle and bulky bandaging. Designed for easy ...
... walker provides comfortable stability for acute ankle ... leg, stress fractures of the lower leg ... ankle. Extension pads for the liner are ... Tide walker with midcalf uprights, is ideal ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: